MERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract
Summary
Merck & Co. ($MRK) received a $156M definitive contract from HHS/ASPR for Ervebo (Ebola vaccine) procurement over 10 years. The contract is small relative to Merck's $60.1B revenue, representing a stable but minor revenue stream. No direct legislative connection was identified.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Merck won a $156M, 10-year contract for Ebola vaccine procurement, but it is too small to significantly impact financials.
- 2.The contract reinforces Merck's position in biodefense but offers no transformational catalyst.
- 3.No direct legislative tailwind was identified; the award is a routine procurement under HHS preparedness authority.
Market Implications
The contract is a small, stable revenue stream for Merck. It does not alter the company's investment thesis or competitive dynamics. Other vaccine pure-plays like $NVAX or $MRNA are not directly affected. The impact is limited to Merck, and even then, it is negligible.
Full Analysis
- The contract: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., was awarded a $156M definitive contract by the Department of Health and Human Services, Office of Assistant Secretary for Preparedness and Response, for procurement of Ervebo, an Ebola vaccine. The contract runs from 2024 to 2034. 2) The public company beneficiary is Merck & Co., Inc.. With annual revenue of $60.1B (FY2025), the $156M contract (~$15.6M/year) represents a negligible 0.03% of revenue. This is a low-impact, routine contract for Merck. 3) No related bills from the provided list directly connect to this contract. The contract falls under the Public Health Service Act's biodefense provisions, but no specific bill authorizing this exact procurement was identified. 4) Supply chain beneficiaries are not clearly identifiable from the contract data. However, contract manufacturing organizations (CMOs) like Thermo Fisher Scientific ($TMO) or Catalent ($CTLT) could potentially benefit if Merck outsources production, but this is speculative. The contract is likely for the finished vaccine product. 5) Historically, government vaccine procurement contracts provide stable, low-margin revenue streams. Similar contracts for pandemic preparedness (e.g., HHS contracts for COVID-19 vaccines) have been larger but follow a similar pattern. For Merck, this is a minor but consistent addition to its vaccine segment.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.6B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.4B Department of Homeland Security Grant
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
LOUSIANA DEPARTMENT OF HEALTH: $16.7B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Contract Details
Recipient
MERCK SHARP & DOHME LLC
Award Amount
$155,843,515
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →